Wellgistics Health Inc (WGRX)
NASDAQHealth CareMedical - DistributionSnapshot 2026-10-29
$3.59+15.06%
Close 2026-07-28 · 1-day change
NASDAQHealth CareMedical - DistributionSnapshot 2026-10-29
Research Workspace
Put WGRX beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Primary pillar under pressure — Company resolves Nasdaq delisting notice: Delisting notice active vs maintained listing.
View ThesisManagement screens weak on capital allocation, margins, market reaction to earnings.
View ManagementThis stock is highly volatile — it swings about 5% on a typical day and fell roughly 95% in its worst 12-month stretch.
View RiskWGRX’s case rests on steady recent performance, despite unsteady management and high risk. No earnings release is recorded, so revenue growth and the latest result remain unknown. The company has no earnings yield because it lost money over the past year. No peer multiple or expectations reading is available to show what prices reflect. An active Nasdaq delisting notice puts its maintained listing under pressure. Our read is provisional, and the thesis is on watch.
Trailing returns as of 2026-07-28. WGRX is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Continue this research
Compare WGRX with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| WGRX Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Health Care (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put WGRX next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Reverse split may affect Nasdaq compliance.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-28. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Bottom 25% on quality vs scored peers
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.
Acquisition aligns with growth objectives.